LONDON, October 2, 2017 /PRNewswire/ --
Malaria, Dengue, Leishmaniasis,Schistosomiasis, Lymphatic Filariasis, Chagas Disease
The Global Treatment for Neglected Tropical Disease market is expected to grow at a CAGR of 7.3% in the second half of the forecast period. The Global Treatment for Neglected Tropical
(Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 157-page report you will receive 71 tables and 80 figures- all unavailable elsewhere.
The 157-page report provides clear detailed insight into the Global Treatment for Neglected Tropical Disease market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
• Global Treatment for Neglected Tropical Disease market forecasts from 2017-2027
• This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by disease type: - Malaria treatments - Dengue treatments - Leishmaniasis - Schistosomiasis - Lymphatic Filariasis - Chagas Disease - Others
For each disease type, the report provides a SWOT analysis, a list of selected drugs and revenue forecasts from 2017-2027 of the leading drugs.
• This report provides revenue forecast for these leading drugs: - Coartem (Novartis) - Clindamycin (Pfizer) - Dengvaxia (Sanofi) - AmBisome (Gilead Sciences) - Impavido (Knight Therapeutics) - ALBENZA (Amedra Pharmaceuticals LLC)
• This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by regional and national market: - North America: US and Canada - Europe: Germany, the UK, France, Spain, Italy, Rest of Europe - Asia-Pacific: Japan, China, India, Rest of Asia - Latin America: Brazil, Mexico, Rest of Latin America - Middle East & Africa: Saudi Arabia, South of Africa, Rest of Middle East & Africa
Each regional market is further broken down by disease type.
• This report provides company overview, financial information, product portfolio and recent developments for the leading companies in the neglected tropical disease market: - Pfizer, Inc. - Bayer - GlaxoSmithKline plc - Merck & Co., Inc. - Novartis International AG - Takeda Pharmaceutical Company Ltd - Sanofi S.A. - Eisai Co., Ltd
Buy our report today Global Treatment for Neglected Tropical Disease Market 2017-2027: Malaria, Dengue, Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease.
To request a report overview of this report please email Sara Peerun at [email protected] or call Tel: +44-(0)-20-7336-6100
Or click on https://www.visiongain.com/Report/2002/Global-Treatment-for-Neglected-Tropical-Disease-Market-2017-2027
List of Companies Mentioned in The Report
Amedra Pharmaceuticals LLC
APP Pharmaceuticals LLC
Asian Development Bank
Eisai Co., Ltd
F. Hoffmann-La Roche AG
Johnson & Johnson
Kadmon Pharmaceuticals LLC
Nicholas Piramal India Ltd.
Novartis International AG
Takeda Pharmaceutical Company Ltd
To see a report overview please email Sara Peerun on [email protected]
SOURCE Visiongain Ltd
Subscribe to our Free Newsletters!
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...
Spinal anesthesia and epidural anesthesia are types of regional anesthesia in which when a drug is ...View All